SUMO-1 promotes association of SNURF (RNF4) with PML nuclear bodies

Experimental Cell Research

Volumn 304, Issue 1, 2005, Pages 224-233

  Häkli, Marika ^a   Karvonen, Ulla ^a   Jänne, Olli A ^a,b   Palvimo, Jorma J ^a,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Nuclear body; PML; SNURF (RNF4); SUMO 1; Transcription

Indexed keywords

NUCLEAR PROTEIN; SMALL NUCLEAR RING FINGER PROTEIN; SUMO 1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL NUCLEUS INCLUSION BODY; CHEMICAL ANALYSIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; TRANSACTIVATION; TRANSCRIPTION REGULATION;

EID: 13544254439     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2004.10.029     Document Type: Article

References (72)

1. J.A. Dyck, G.G. Mau, W.H. Miller Jr., J.D. Chen, A. Kakizuka, and R.M. Evans A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein Cell 76 1994 333 343
2. M.N. Boddy, K. Howe, L.D. Etkin, E. Solomon, and P.S. Freemont PIC 1 a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia Oncogene 13 1996 971 982
3. M. Alcalay, L. Tomassoni, E. Colombo, S. Stoldt, F. Grignani, M. Fagioli, L. Szekely, K. Helin, and P.G. Pelicci The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein Mol. Cell. Biol. 18 1998 1084 1093
4. S. Zhong, P. Salomoni, S. Ronchetti, A. Guo, D. Ruggero, and P.P. Pandolfi Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis J. Exp. Med. 191 2000 631 640
5. M. Pearson, R. Carbone, C. Sebastiani, M. Cioce, M. Fagioli, S. Saito, Y. Higashimoto, E. Appella, S. Minucci, P.P. Pandolfi, and P.G. Pelicci PML regulates p53 acetylation and premature senescence induced by oncogenic Ras Nature 406 2000 207 210
6. R. Carbone, M. Pearson, S. Minucci, and P.G. Pelicci PML NBs associate with the hMre11 complex and p53 at sites of irradiation induced DNA damage Oncogene 21 2002 1633 1640
7. F.A. Mallette, S. Goumard, M.F. Gaumont-Leclerc, O. Moiseeva, and G. Ferbeyre Human fibroblasts require the Rb family of tumor suppressors but not p53 for PML-induced senescence Oncogene 23 2004 91 99
8. H. de The, C. Lavau, A. Marchio, C. Chomienne, L. Degos, and A. Dejean The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR Cell 66 1991 675 684
9. A. Kakizuka, W.H. Miller Jr., K. Umesono, R.P. Warrell Jr., S.R. Frankel, V.V. Murty, E. Dmitrovsky, and R.M. Evans Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor PML Cell 66 1991 663 674
10. M.H. Koken, F. Puvion-Dutilleul, M.C. Guillemin, A. Viron, G. Linares-Cruz, N. Stuurman, L. de Jong, C. Szostecki, F. Calvo, and C. Chomienne The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion EMBO J. 13 1994 1073 1083
11. K. Weis, S. Rambaud, C. Lavau, J. Jansen, T. Carvalho, M. Carmo-Fonseca, A. Lamond, and A. Dejean Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells Cell 76 1994 345 356
12. K. Jensen, C. Shiels, and P.S. Freemont PML protein isoforms and the RBCC/TRIM motif Oncogene 20 2001 7223 7233
13. K.L. Borden, M.N. Boddy, J. Lally, N.J. O'Reilly, S. Martin, K. Howe, E. Solomon, and P.S. Freemont The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto-oncoprotein PML EMBO J. 14 1995 1532 1541
14. K.L. Borden, J.M. Lally, S.R. Martin, N.J. O'Reilly, E. Solomon, and P.S. Freemont In vivo and in vitro characterization of the B1 and B2 zinc-binding domains from the acute promyelocytic leukemia protooncoprotein PML Proc. Natl. Acad. Sci. U. S. A. 93 1996 1601 1606
15. M. Fagioli, M. Alcalay, L. Tomassoni, P.F. Ferrucci, A. Mencarelli, D. Riganelli, F. Grignani, T. Pozzan, I. Nicoletti, F. Grignani, and P.G. Pelicci Cooperation between the RING + B1-B2 and coiled-coil domains of PML is necessary for its effects on cell survival Oncogene 16 1998 2905 2913
16. E. Duprez, A.J. Saurin, J.M. Desterro, V. Lallemand-Breitenbach, K. Howe, M.N. Boddy, E. Solomon, H. de The, R.T. Hay, and P.S. Freemont SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation J. Cell Sci. 112 1999 381 393
17. T. Kamitani, K. Kito, H.P. Nguyen, H. Wada, T. Fukuda-Kamitani, and E.T. Yeh Identification of three major sentrinization sites in PML J. Biol. Chem. 273 1998 26675 26682
18. S. Zhong, S. Müller, S. Ronchetti, P.S. Freemont, A. Dejean, and P.P. Pandolfi Role of SUMO-1 modified PML in nuclear body formation Blood 95 2000 2748 2752
19. A.M. Ishov, A.G. Sotnikov, D. Negorev, O.V. Vladimirova, N. Neff, T. Kamitani, E.T. Yeh, J.F. Strauss III, and G.G. Maul PML is critical for ND10 formation and recruits the PML-interacting protein Daxx to this nuclear structure when modified by SUMO-1 J. Cell Biol. 147 1999 221 234
20. J.S. Seeler, and A. Dejean Nuclear and unclear functions of SUMO Nat. Rev. Mol. Cell Biol. 4 2003 690 699
21. E.S. Johnson, and A.A. Gupta An E3-like factor that promotes SUMO conjugation to the yeast septins Cell 106 2001 735 744
22. N. Kotaja, U. Karvonen, O.A. Jänne, and J.J. Palvimo PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases Mol. Cell. Biol. 22 2002 5222 5234
23. A. Pichler, A. Gast, J.S. Seeler, A. Dejean, and F. Melchior The nucleoporin RanBP2 has SUMO1 E3 ligase activity Cell 108 2002 109 120
24. M.H. Kagey, T.A. Melhuish, and D. Wotton The polycomb protein Pc2 is a SUMO E3 Cell 113 2003 127 137
25. A. Minty, X. Dumont, M. Kaghad, and D. Caput Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif J. Biol. Chem. 275 2000 36316 36323
26. C. Hoege, B. Pfander, G.L. Moldovan, G. Pyrowolakis, and S. Jentsch RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO Nature 419 2002 135 141
27. P.S. Lee, C. Chang, D. Liu, and R. Derynck Sumoylation of Smad4 the common Smad mediator of transforming growth factor-beta family signaling J. Biol. Chem. 278 2003 27853 27863
28. M.H. Tatham, E. Jaffray, O.A. Vaughan, J.M. Desterro, C.H. Botting, J.H. Naismith, and R.T. Hay Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9 J. Biol. Chem. 276 2001 35368 35374
29. F. Melchior, M. Schergaut, and A. Pichler SUMO: ligases isopeptidases and nuclear pores Trends Biochem. Sci. 28 2003 612 618
30. A.-M. Moilanen, H. Poukka, U. Karvonen, M. Häkli, O.A. Jänne, and J.J. Palvimo Identification of a novel RING finger protein as a coregulator in steroid receptor-mediated gene transcription Mol. Cell. Biol. 18 1998 5128 5139
31. L. Chiariotti, G. Benvenuto, M. Fedele, M. Santoro, A. Simeone, A. Fusco, and C.B. Bruni Identification and characterization of a novel RING-finger gene (RNF4) mapping at 4p16.3 Genomics 47 1998 258 265
32. H. Poukka, P. Aarnisalo, H. Santti, O.A. Jänne, and J.J. Palvimo Coregulator small nuclear RING finger protein (SNURF) enhances Sp1- and steroid receptor-mediated transcription by different mechanisms J. Biol. Chem. 275 2000 571 579
33. C. Lyngsø, G. Bouteiller, C.K. Damgaard, D. Ryom, S. Sanchez-Munoz, P.L. Nørby, B.J. Bonven, and P. Jørgensen Interaction between the transcription factor SPBP and the positive cofactor RNF4. An interplay between protein binding zinc fingers J. Biol. Chem. 275 2000 26144 26149
34. F.J. Kaiser, T. Möröy, G.T. Chang, B. Horsthemke, and H.J. Lüdecke The RING finger protein RNF4 a co-regulator of transcription interacts with the TRPS1 transcription factor J. Biol. Chem. 278 2003 38780 38785
35. M. Fedele, G. Benvenuto, R. Pero, B. Majello, S. Battista, F. Lembo, E. Vollono, P.M. Day, M. Santoro, L. Lania, C.B. Bruni, A. Fusco, and L. Chiariotti A novel member of the BTB/POZ family PATZ associates with the RNF4 RING finger protein and acts as a transcriptional repressor J. Biol. Chem. 275 2000 7894 7901
36. M. Häkli, U. Karvonen, O.A. Jänne, and J.J. Palvimo The RING finger protein SNURF is a bifunctional protein possessing DNA binding activity J. Biol. Chem. 276 2001 23653 23660
37. M. Häkli, K.L. Lorick, A.M. Weissman, O.A. Jänne, and J.J. Palvimo Transcriptional coregulator SNURF (RNF4) possesses ubiquitin E3 ligase activity FEBS Lett. 560 2004 56 62
38. N. Galili, S. Nayak, J.A. Epstein, and C.A. Buck Rnf4 a RING protein expressed in the developing nervous and reproductive systems interacts with Gscl a gene within the DiGeorge critical region Dev. Dyn. 218 2000 102 111
39. W. Yan, S.J. Hirvonen-Santti, J.J. Palvimo, J. Toppari, and O.A. Jänne Expression of the nuclear RING finger protein SNURF/RNF4 during rat testis development suggests a role in spermatid maturation Mech. Dev. 118 2002 247 253
40. R. Pero, F. Lembo, D. Di Vizio, A. Boccia, P. Chieffi, M. Fedele, G.M. Pierantoni, P. Rossi, R. Iuliano, M. Santoro, G. Viglietto, C.B. Bruni, A. Fusco, and L. Chiariotti RNF4 is a growth inhibitor expressed in germ cells but not in human testicular tumors Am. J. Pathol. 159 2001 1225 1230
41. S.J. Hirvonen-Santti, A. Rannikko, H. Santti, S. Savolainen, M. Nyberg, O.A. Jänne, and J.J. Palvimo Down-regulation of estrogen receptor beta and transcriptional coregulator SNURF/RNF4 in testicular germ cell cancer Eur. Urol. 44 2003 742 747
42. J. Zuber, O.I. Tchernitsa, B. Hinzmann, A.C. Schmitz, M. Grips, M. Hellriegel, C. Sers, A. Rosenthal, and R. Schafer A genome-wide survey of RAS transformation targets Nat. Genet. 24 2000 144 152
43. H. Poukka, U. Karvonen, O.A. Jänne, and J.J. Palvimo Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1) Proc. Natl. Acad. Sci. U. S. A. 97 2000 14145 14150
44. S. Weger, E. Hammer, and M. Engstler The DNA topoisomerase I binding protein topors as a novel cellular target for SUMO-1 modification characterization of domains necessary for subcellular localization and sumoylation Exp. Cell Res. 290 2003 13 27
45. J. Wang, C. Shiels, P. Sasieni, P.J. Wu, S.A. Islam, P.S. Freemont, and D. Sheer Promyelocytic leukemia nuclear bodies associate with transcriptionally active genomic regions J. Cell Biol. 164 2004 515 526
46. C.H. Eskiw, G. Dellaire, and D.P. Bazett-Jones Chromatin contributes to structural integrity of promyelocytic leukemia bodies through a SUMO-1-independent mechanism J. Biol. Chem. 279 2004 9577 9585
47. J.S. Seeler, A. Marchio, D. Sitterlin, C. Transy, and A. Dejean Interaction of SP100 with HP1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment Proc. Natl. Acad. Sci. U. S. A. 95 1998 7316 7321
48. D.B. Bloch, J.D. Chiche, D. Orth, S.M. de la Monte, A. Rosenzweig, and K.D. Bloch Structural and functional heterogeneity of nuclear bodies Mol. Cell. Biol. 19 1999 4423 4430
49. F.M. Boisvert, M.J. Hendzel, and D.P. Bazett-Jones Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA J. Cell Biol. 148 2000 283 292
50. V.J. LaMorte, J.A. Dyck, R.L. Ochs, and R.M. Evans Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body Proc. Natl. Acad. Sci. U. S. A. 95 1998 4991 4996
51. V. Doucas, M. Tini, D.A. Egan, and R.M. Evans Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling Proc. Natl. Acad. Sci. U. S. A. 96 1999 2627 2632
52. S. Zhong, L. Delva, C. Rachez, C. Enciarelli, D. Gandini, H. Zhang, S. Kalantry, L.P. Freedman, and P.P. Pandolfi A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins Nat. Genet. 23 1999 287 295
53. H. Li, C. Leo, J. Zhu, X. Wu, J. O'Neil, E.J. Park, and J.D. Chen Sequestration and inhibition of Daxx-mediated transcriptional repression by PML Mol. Cell. Biol. 20 2000 1784 1796
54. W.S. Wu, S. Vallian, E. Seto, W.M. Yang, D. Edmondson, S. Roth, and K.S. Chang The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases Mol. Cell. Biol. 21 2001 2259 2268
55. J.L. Best, S. Ganiatsas, S. Agarwal, A. Changou, P. Salomoni, O. Shirihai, P.B. Meluh, P.P. Pandolfi, and L.I. Zon SUMO-1 protease-1 regulates gene transcription through PML Mol. Cell 10 2002 843 855
56. F. Lehembre, S. Müller, P.P. Pandolfi, and A. Dejean Regulation of Pax3 transcriptional activity by SUMO-1-modified PML Oncogene 20 2001 1 9
57. D.Y. Lin, M.Z. Lai, D.K. Ann, and H.M. Shih Promyelocytic leukemia protein (PML) functions as a glucocorticoid receptor co-activator by sequestering Daxx to the PML oncogenic domains (PODs) to enhance its transactivation potential J. Biol. Chem. 278 2003 15958 15965
58. A. Möller, H. Sirma, T.G. Hofmann, S. Rueffer, E. Klimczak, W. Droge, H. Will, and M.L. Schmitz PML is required for homeodomain-interacting protein kinase 2 (HIPK2)-mediated p53 phosphorylation and cell cycle arrest but is dispensable for the formation of HIPK domains Cancer Res. 63 2003 4310 4314
59. O.G. Engelhardt, C. Boutell, A. Orr, E. Ullrich, O. Haller, and R.D. Everett The homeodomain-interacting kinase PKM (HIPK-2) modifies ND10 through both its kinase domain and a SUMO-1 interaction motif and alters the posttranslational modification of PML Exp. Cell Res. 283 2003 36 50
60. V. Fogal, M. Gostissa, P. Sandy, P. Zacchi, T. Sternsdorf, K. Jensen, P.P. Pandolfi, H. Will, C. Schneider, and G. Del Sal Regulation of p53 activity in nuclear bodies by a specific PML isoform EMBO J. 19 2000 6185 6195
61. J.H. Ahn, Y. Xu, W.J. Jang, M.J. Matunis, and G.S. Hayward Evaluation of interactions of human cytomegalovirus immediate-early IE2 regulatory protein with small ubiquitin-like modifiers and their conjugation enzyme Ubc9 J. Virol. 75 2001 3859 3872
62. S.W. Ryu, S.K Chae, and E. Kim Interaction of Daxx a Fas binding protein with sentrin and Ubc9 Biochem. Biophys. Res. Commun. 279 2000 6 10
63. X. Wei, Z.K. Yu, A. Ramalingam, S.R. Grossman, J.H. Yu, D.B. Bloch, and C.G. Maki Physical and functional interactions between PML and MDM2 J. Biol. Chem. 278 2003 29288 29297
64. H. Zhu, L. Wu, and C.G. Maki MDM2 and promyelocytic leukemia antagonize each other through their direct interaction with p53 J. Biol. Chem. 278 2003 49286 49292
65. A. Rosendorff, D. Illanes, G. David, J. Lin, E. Kieff, and E. Johannsen EBNA3C coactivation with EBNA2 requires a SUMO homology domain J. Virol. 78 2004 367 377
66. S. Vallian, K.V. Chin, and K.S. Chang The promyelocytic leukemia protein interacts with Sp1 and inhibits its transactivation of the epidermal growth factor receptor promoter Mol. Cell. Biol. 18 1998 7147 7156
67. E.J. Kim, J.S. Park, and S.J. Um Identification of Daxx interacting with p73 one of the p53 family and its regulation of p53 activity by competitive interaction with PML Nucleic Acids Res. 31 2003 5356 5367
68. Z.G. Wang, D. Ruggero, S. Ronchetti, S. Zhong, M. Gaboli, R. Rivi, and P.P. Pandolfi PML is essential for multiple apoptotic pathways Nat. Genet. 20 1998 266 272
69. Z.G. Wang, L. Delva, M. Gaboli, R. Rivi, M. Giorgio, C. Cordon-Cardo, F. Grosveld, and P.P. Pandolfi Role of PML in cell growth and the retinoic acid pathway Science 279 1998 1547 1551
70. M. Pearson, and P.G. Pelicci PML interaction with p53 and its role in apoptosis and replicative senescence Oncogene 20 2001 7250 7256
71. P. Salomoni, and P.P. Pandolfi The role of PML in tumor suppression Cell 108 2002 165 170
72. C. Gurrieri, P. Capodieci, R. Bernardi, P.P. Scaglioni, K. Nafa, L.J. Rush, D.A. Verbel, C. Cordon-Cardo, and P.P. Pandolfi Loss of the tumor suppressor PML in human cancers of multiple histologic origins J. Natl. Cancer Inst. 96 2004 269 279